109 related articles for article (PubMed ID: 9504401)
1. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.
Capra V; Bolla M; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Br J Pharmacol; 1998 Feb; 123(3):590-8. PubMed ID: 9504401
[TBL] [Abstract][Full Text] [Related]
2. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the pharmacological activity of the pure cysteinyl-leukotriene receptor antagonists CGP 45715A (iralukast) and CGP 57698 in human airways.
Capra V; Ravasi S; Bolla M; Viappiani S; Pagliardini S; Belloni PA; Mezzetti M; Folco GC; Nicosia S; Rovati GE
Adv Exp Med Biol; 1999; 469():313-8. PubMed ID: 10667347
[No Abstract] [Full Text] [Related]
4. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
Metters KM; Gareau Y; Lord A; Rochette C; Sawyer N
J Pharmacol Exp Ther; 1994 Jul; 270(1):399-406. PubMed ID: 8035338
[TBL] [Abstract][Full Text] [Related]
5. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
6. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
O'Sullivan BP; Mong S
Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
[TBL] [Abstract][Full Text] [Related]
7. Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
Shirley JT; Cheng JB
J Pharmacol Exp Ther; 1991 Aug; 258(2):531-6. PubMed ID: 1650832
[TBL] [Abstract][Full Text] [Related]
8. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
[TBL] [Abstract][Full Text] [Related]
9. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615.
Aharony D; Falcone RC; Krell RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):921-6. PubMed ID: 2826761
[TBL] [Abstract][Full Text] [Related]
12. Leukotrienes: possible mediators in bronchial asthma.
Piper PJ
Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
[TBL] [Abstract][Full Text] [Related]
13. The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.
Mazzetti L; Franchi-Micheli S; Nistri S; Quattrone S; Simone R; Ciuffi M; Zilletti L; Failli P
Br J Pharmacol; 2003 Feb; 138(4):707-15. PubMed ID: 12598425
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
Zwaagstra ME; Timmerman H; van de Stolpe AC; de Kanter FJ; Tamura M; Wada Y; Zhang MQ
J Med Chem; 1998 Apr; 41(9):1428-38. PubMed ID: 9554876
[TBL] [Abstract][Full Text] [Related]
17. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma.
Fukushima C; Shimoda T; Matsuse H; Matsuo N; Takao A; Obase Y; Kohno S; Asai S
Ann Allergy Asthma Immunol; 1998 Mar; 80(3):245-50. PubMed ID: 9532973
[TBL] [Abstract][Full Text] [Related]
18. Guanyl-5'-yl-lmidodiphosphate regulation of ligand binding to LTD4 receptors on guinea pig lung membranes.
Catanese CA; Falcone RC; Aharony D
J Pharmacol Exp Ther; 1989 Dec; 251(3):846-51. PubMed ID: 2557419
[TBL] [Abstract][Full Text] [Related]
19. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and distribution of specific binding sites for leukotriene C4 in human bronchi.
Civelli M; Oliva D; Mezzetti M; Nicosia S
J Pharmacol Exp Ther; 1987 Sep; 242(3):1019-24. PubMed ID: 2821221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
